Medicinal Cannabis Scheme consultation

Closes 7 Aug 2019

Consultation Contents

The questions have been organised by section and by the audience(s) we think the question is most relevant for. For example, much of Part E: Prescribing has questions for prescribers, though some of these may also be of interest to consumers, industry, or other groups. We encourage you to answer or provide comments on any proposals or questions you feel are relevant.

If you have filled out the questions on one page, select ‘Continue’ to return to the contents page and complete the other sections you are interested in.

You can also can complete your submission over a number of sessions and save it as you go by selecting ‘Save and come back later’. You will then be sent an email with a unique link that will let you return to edit and submit your response. This link can be shared with your colleagues if you require their contribution to, or review of, the submission.

Once you have completed your submission, you will be sent a pdf copy for your records.

Page Response
Your details and privacy
0 percent complete
0 of 9 questions answered
Overall comments: Questions for all
0 percent complete
0 of 2 questions answered
A4 – Equity: Questions for all
0 percent complete
0 of 1 questions answered
A4 – Equity: Questions for patients/consumers
0 percent complete
0 of 1 questions answered
A4 – Equity: Questions for prescribers
0 percent complete
0 of 2 questions answered
B2 – Proposed quality standards for cultivation: Questions for industry and researchers
0 percent complete
0 of 11 questions answered
B3 – Proposed quality standards for manufacturing: Questions for all
0 percent complete
0 of 7 questions answered
B3 – Proposed quality standards for manufacturing: Questions for industry
0 percent complete
0 of 8 questions answered
B3 – Proposed quality standards for manufacturing: Questions for prescribers
0 percent complete
0 of 2 questions answered
B4 – Proposed quality standards for active pharmaceutical ingredients: Questions for industry
0 percent complete
0 of 1 questions answered
B4 – Proposed quality standards for active pharmaceutical ingredients: Questions for all
0 percent complete
0 of 2 questions answered
B4 – Finished product quality standard – dose form requirements: Questions for all
0 percent complete
0 of 3 questions answered
B4 – Finished product quality standard – dose form requirements: Questions for prescribers
0 percent complete
0 of 2 questions answered
B4 – Finished product quality standard – product specifications: Questions for industry
0 percent complete
0 of 2 questions answered
B4 – Testing to meet the product quality standards: Questions for industry
0 percent complete
0 of 2 questions answered
C3 – Licensing under the Scheme: Questions for industry
0 percent complete
0 of 2 questions answered
C4 – Licence to Cultivate: Questions for industry and researchers
0 percent complete
0 of 4 questions answered
C5 – Declaration to allow the use of local varieties: Questions for all
0 percent complete
0 of 1 questions answered
C6 – Transition from research to commercial: Questions for industry and researchers
0 percent complete
0 of 1 questions answered
C7 – Licence to Manufacture: Questions for industry
0 percent complete
0 of 1 questions answered
C8 – Licence to Sell Medicines by Wholesale: Questions for industry
0 percent complete
0 of 1 questions answered
C9 – Licence to Supply Unconsented Medicinal Cannabis Products under Misuse of Drugs Act: Question for industry
0 percent complete
0 of 2 questions answered
C12 – Import: Questions for industry
0 percent complete
0 of 2 questions answered
C12 – Import: Questions for all
0 percent complete
0 of 1 questions answered
C12 – Export: Questions for industry
0 percent complete
0 of 3 questions answered
C12 – Export: Questions for all
0 percent complete
0 of 1 questions answered
D – Distribution: Questions for industry
0 percent complete
0 of 1 questions answered
E1 – Approval to prescribe: Questions for prescribers
0 percent complete
0 of 1 questions answered
E1 – Approval to prescribe: Questions for prescribers and pharmacists
0 percent complete
0 of 1 questions answered
E1 – Approval to prescribe: Questions for all
0 percent complete
0 of 1 questions answered
E1 – On-label use of approved products: Questions for prescribers
0 percent complete
0 of 4 questions answered
E1 – Off-label use of approved products: Questions for all
0 percent complete
0 of 2 questions answered
E1 – Off-label use of approved products: Questions for prescribers
0 percent complete
0 of 2 questions answered
E1 – Unapproved, controlled drugs that meet the quality standards: Questions for all
0 percent complete
0 of 1 questions answered
E1 – Unapproved, controlled drugs that meet the quality standards: Questions for prescribers
0 percent complete
0 of 2 questions answered
E1 – Unapproved, controlled drugs that do not meet the quality standards: Questions for all
0 percent complete
0 of 1 questions answered
E1 – Unapproved, controlled drugs that do not meet the quality standards: Questions for prescribers
0 percent complete
0 of 2 questions answered
E1 – CBD products: Questions for prescribers
0 percent complete
0 of 2 questions answered
E1 – CBD products: Questions for all
0 percent complete
0 of 1 questions answered
E3 – Provision of information to prescribers on prescribing of medicinal cannabis products: Questions for all
0 percent complete
0 of 1 questions answered
E3 – Provision of information to prescribers on prescribing of medicinal cannabis products: Questions for prescribers and pharmacists
0 percent complete
0 of 3 questions answered
E3 – Provision of information to prescribers on prescribing of medicinal cannabis products: Questions for prescribers
0 percent complete
0 of 2 questions answered
E3 – Provision of information to prescribers on prescribing of medicinal cannabis products: Questions for patients/consumers
0 percent complete
0 of 3 questions answered
F – Post market controls: Questions for all
0 percent complete
0 of 2 questions answered
F – Enforcement powers: Questions for all
0 percent complete
0 of 1 questions answered
F – Collection of information: Questions for all
0 percent complete
0 of 1 questions answered
G – Fees: Questions for researchers
0 percent complete
0 of 1 questions answered
G – Fees: Questions for industry
0 percent complete
0 of 2 questions answered
G – Fees: Questions for all
0 percent complete
0 of 2 questions answered